The purpose of this study was to describe the clinical features at onset and outcome and the diagnostic approach in subjects with bronchiolitis obliterans-organizing pneumonia (BOOP). Over a 7-year period we observed 78 cases of biopsy-proven bronchiolitis obliterans-organizing pneumonia, in which well documented clinical and radiographic data were available. The ®nal diagnosis of BOOP was validated when patients presented: (i) negative microbiological analysis on BAL¯uid; (ii) a well documented improvement either spontaneous, or after steroid treatment or (iii) cases with progressive respiratory failure and increasing radiographic shadows, an open lung biopsy or autopsy that excluded other entities. There were 42 males and 36 females; the mean age was 6112 years (range 12±85 years). Forty-two (54%) patients were current smokers, 25 (32%) had never smoked and 11 (14%) were ex-smokers. The clinical pattern at presentation of BOOP was more frequently similar to classical acute or sub-acute infectious pneumonia. Fever (63%), dyspnoea (58%) and dry cough (53%) were the typical symptoms on admission. A¯u-like syndrome preceeding BOOP was observed in 21 cases (27%). Inspiratory crackles (78%) were the most typical ®nding at physical examination. However, 13% of the patients were asymptomatic and an abnormal chest X-ray ®lm was the reason for seeking medical attention. Radiographically the most frequent pattern of BOOP was a unilateral consolidation (44%) with lower ®eld predominance. A migratory behaviour was present in 22% of the cases. High-resolution computed tomographic (HR-CT) scan when performed, was more sensitive in detecting ground glass in®ltrates, sub-pleural or peri-bronchovascular distribution or the presence of nodules or cavitation.
Introduction
Bronchiolitis obliterans-organizing pneumonia (BOOP) is a distinct clinicopathological entity which usually responds signi®cantly to corticosteroids (1±6). Most cases of BOOP are idiopathic (in this case a synonym used in Europe is cryptogenic organizing pneumonia). It may also occur in association with connective tissue disease, with variable immunode®ciency syndrome, HIV infection, hepatitis viral infection, bacterial infections, graft vs. host disease (GVHD) and bone marrow transplant (BMT), with lung transplant, drug toxicity, radiation toxicity or it may be associated with lung tumours, ulcerative colitis and myelodysplastic syndrome. Spiteri and Coll reported a seasonal occurence of BOOP with biochemical cholestasis (7) . Exposure to paint aerosols in textile workshops has been reported as a novel cause of bronchilitis obliteransorganizing pneumonia (8) .
Pathogenetic studies have provided evidence of an increase in lung microenviroment in the number of activated T-lymphocytes, indicative of an immune response, and hence the production of cytokines and growth factors (9) . Mast cell hyperplasia and evidence for extracellular release of tryptase have been documented on bronchoalveolar lavage (BAL)¯uid (10) . Increased interleukin 8 (IL-8) and interleukin 6 (IL-6) mRNA expression, platelet-derived growth factor (PDGF) and granulocyte/ macrophage colony-stimulating factor (GM-CSF) immunoreactivity have also been found in lung specimens obtained from patients with BOOP (9,11±13). Most patients experience a good response to therapy but a few series have reported cases with rapidly progressive BOOP (14) . Bronchoalveolar lavage ®ndings are characteristic and BAL coupled with transbronchial lung biopsy may be sucient for a de®nitive diagnosis although surgical lung biopsy has till now been considered necessary in order to con®rm a clinical diagnosis (15±17).
The purpose of this study was to describe the clinical and roentgenological features at onset and outcome and the diagnostic approach in subjects with bronchiolitis obliterans-organizing pneumonia. Over a 7-year period we observed 78 cases of biopsy-proven BOOP in which well documented clinical and radiographic data were available.
Materials and methods
From January 1990 to December 1997 we observed 78 cases of biopsy-proven BOOP. All patients were studied for connective tissue disease, ANCA antibodies, serological assays for Mycoplasma pneumoniae, Chlamydia trachomatis, Legionella pneumophila, Coxiella burneti, Adenovirus, respiratory syncitial virus, Cytomegalovirus, Herpes simplex virus, Hepatitis virus (HBV, HCV), In¯uenza and Parain¯uenza virus. Chlamydia pneumoniae serological assay has been performed only recently (for 2 years). Clinical evaluation included immunological status, drug consumption, symptoms at presentation, routine biochemical data, medication requirement and outcome.
The radiographs were reviewed by experienced radiologists. The patterns of abnormalities were classi®ed as airspace consolidation (unilateral or bilateral, migratory or ®xed), nodules or reticulonodular. HRCT scan ®lms from patients with non-pseudoneoplastic lesions were available in 35 patients. All the lung specimens and BAL slides were reviewed by experienced pulmonary pathologists. A BOOP pattern was de®ned when histological changes characterized by patchy airspace organization with buds of loose connective tissue containing ®broblast and in¯ammatory cells within airspaces (bronchioles and alveolar spaces) were present on lung tissue specimens.
All patients enrolled in the study were required to meet the following criteria: (i) radiologic lung in®ltrate(s) or nodule(s); (ii) lung biopsy con®rming BOOP; (iii) negative microbiological analysis on BAL¯uid; (iv) a well documented improvement that was either spontaneous, or after exclusive steroid treatment; (v) cases with progressive respiratory failure and increasing radiographic shadows, an open lung biopsy or autopsy that excluded other entities.
Results

PATIENTS' CHARACTERISTICS
During the 7-year study, 78 patients were identi®ed with a con®rmatory diagnosis of organizing pneumonia or BOOP.
There were 42 males and 36 females in the study, with an age range of 12±85 years; the age meanSD was 6112 years. Forty-two patients (54%) were current smokers, 25 (32%) had never smoked and 11 (14%) were ex-smokers (they had stopped smoking at least 12 months before the diagnosis was made).
CLINICAL MANIFESTATIONS AND ASSOCIATED CONDITIONS
Clinical features are summarized in Table 1 . The most common presenting symptoms were dyspnoea and fever lasting from 1 week to 7 months (11085 days). Four patients (all of whom had idiopathic BOOP) presented a rapid progressive respiratory failure needing mechanical ventilation. In two cases dyspnoea and fever were present 14 and 24 days respectively before admission. In the other two cases the duration of symptoms (fever, asthenia and eort dyspnoea) before admission to the respiratory intensive care unit was 3 and 7 months respectively. Fever was continuous and low-grade or intermittent in 32 patients (41%); 18 patients (23%) were admitted to the hospital for acute fever consistent with a diagnosis of acute bacterial pneumonia. A¯u-like syndrome for the 3±4 weeks preceeding BOOP was described in 21 patients (27%). Physical examination revealed inspiratory crackles in 61 cases (78%) and wheezing in 20 cases (26%).
The clinical variants of BOOP are reported in Table 2 . Most of the patients [52 cases (68%)] had no associated condition and were reported as idiopathic; in ®ve cases (6%) BOOP was related to radiotherapy for ductal breast carcinoma. Symptoms appeared 13±24 weeks after completion of radiotherapy (46±50 Grays delivered) and the radiographic shadows (in every case the ®rst radiographic lesion was observed under the irradiated area) were migratory in four cases.
Four patients had connective tissue disease (two rheumatoid arthritis, one polymiositis, and one systemic lupus erythematosus). Another later developed polymiositis. In seven cases BOOP was related to drug toxicity (amiodarone in four cases, polychemotherapy for acute myelogenous leukaemia and carcinoma of the stomach in two cases, pyrimethamine-sulfadiazine in a 12-year-old girl with primary toxoplasma infection). Serological assays demonstrated a recent Mycoplasma pneumoniae infection in two cases and Chlamydia pneumoniae infection in one case. In all three cases we observed a clear clinical and roentgenological improvement only after steroid therapy. Two patients developed organizing pneumonia 60 and 360 days respectively after their allogenic bone marrow transplant for acute myelogenous leukaemia. Both patients had manifestations of graft vs. host disease. In one patient BOOP developed 120 days after autologous bone marrow transplantation for non-Hodgkin lymphoma (BCNU, EDX and VP were used for induction).
ROENTGENOGRAPHIC MANIFESTATIONS
The radiographic abnormalities are recorded in Table 3 . Patchy, unilateral consolidation was seen in 34 cases (44%), with a migratory behaviour in nine patients (12%). Bilateral patchy acinar shadows were observed in 31 patients (40%), and were preceeded in eight patients (10%) by a unilateral acinar lesion. In 10 cases (13%) the chest X-ray ®lm showed a nodular (pseudoneoplastic) lesion and in three cases a bilateral reticulonodular pattern was described.
The shadows were observed in the upper lung ®elds in 23 cases (29%) and predominantly in the lower ®elds in 55 patients (71%). Unilateral small pleural eusions were present in four cases (5%).
HRCT scan ®ndings are reported in Table 4 . Pleural based alveolar opaci®cation was the more frequent aspect. However areas of ground glass attenuation were detected in 2/13, in which radiographically the lesion appeared to be focal. Halo sign, atoll sign and centrilobular nodules were rarely detected.
BRONCHOALVEOLAR LAVAGE
Bronchoalveolar lavage analysis was completed in 67 cases (86%). Total number of cells was 418229 (610 3 ml 71 ). Lymphocytes were 45Á022Á5% of total cells. In detail, a lymphocytosis of more than 25% was observed in 41 cases (61%) and in these cases the mean value of lymphoid cells was 56Á716Á5%. The CD4/CD8 ratio was less than one in 30 cases (45%) and greater than 2Á7 in only two cases (5 and 5Á07 respectively). It was within the normal range (1±2Á7) in 34 cases (51%). Neutrophils were slightly increased (8Á611Á7%). In detail neutrophils in BAL¯uid were more than 5% in 21 patients (31%): in these cases the mean value of neutrophils was 17Á314Á4%. In patients with rapid respiratory failure neutrophils were 44%, 39%, 30% and 14% respectively. Eosinophils were slightly increased (>1% of total nonepithelial cells) in 30 (45%) cases (meanSD 5Á152Á9%). Mast cells were detected in 16 (24%) cases (meanSD 2Á32Á14%) and plasma cells were signi®cantly increased (6%) in only one case. No phenotypical B cells (CD20-positive cells) were higher in percentage except in one case (in which they were 12%, with politypic expression of light chains). In six cases atypical epithelial cells (marked by monoclonal antibodies against low weight cytokeratins) were observed. In four cases these cells were detected in patients with evident respiratory failure and in another two cases with an alveolar in®ltrate suggesting infection or alveolar cell carcinoma. In all cases a diagnosis of alveolar cell carcinoma was excluded by surgical (®ve cases) or autopic (one case) examinations. In two cases these cells were associated with extracellular amorphous cyanophilic material.
DIAGNOSTIC PROCEDURES
Fifty-eight patients (74%) had a diagnosis of BOOP on transbronchial lung biopsy (TBB) specimens. In 18 cases (23%) the diagnosis was made on surgical biopsy specimens (thoracotomy or video-assisted thoracoscopic biopsy). In one case transthoracic biopsy was diagnostic. In one case the diagnosis was con®rmed on autoptic specimens. In particular, in the group of patients with respiratory failure needing mechanical ventilation, the diagnosis was con®rmed by transbronchial lung biopsy (n=2) (in both cases steroid treatment determined a rapid clinico-radiological improvement), by open lung biopsy (n=1) (the patient died 2 weeks after surgical biopsy in spite of treatment) and after autopsy (n=1). Lung biopsy specimens were considered positive for BOOP if they showed buds of granulation tissue (Masson bodies) within the small airways and alveoli, the in®ltration of alveolar walls with chronic in¯ammatory cells and the preservation of alveolar architecture.
In the present study BAL results were consistent with the clinical diagnosis of BOOP in nine cases in which TBB was not diagnostic in agreement with arbitrary cut-o levels for the BAL percentage previously described (lymphocytosis more than 25% with a CD4/CD8 ratio 5 0Á9, combined with at least two of the following criteria: foamy macrophages > 20% and/or neutrophils of > 5% and/or eosinophils > 2% and 5 25%) (17) .
LABORATORY DATA
Erythrocyte sedimentation rate (ERS) was over 30 mm h 71 in the ®rst hour in 63 cases (81%). Lactate-dehydrogenase (LDH) was above normal in 18 cases (23%). A slight eosinophilia was observed in six cases (8%). In one case biochemical cholestasis was detected. Anti-neutrophil cytoplasmic antibodies (ANCA) were negative in all cases whereas anti-nuclear antibodies (ANA) were positive in two patients (without a connective-vascular disease).
TREATMENT AND OUTCOME
Sixty patients (77%) received methyl-prednisolone therapy. The mean dose was 40 mg (range 20±120 mg day 71 ) for 6 weeks, then tapering to a lower dosage for 6±9 months. In this group of patients we had a recurrence of symptoms and chest X-ray abnormalities on reducing the dose of methyl- prednisolone or shortly after stopping therapy in 15 cases (26%). Three patients died (4%) in spite of steroid (two cases) and steroid plus cyclophosphamide therapy (one case). All cases were classi®ed as idiopathic BOOP. In two patients a BOOP pattern was detected in both lungs at autopsy; in the last one at autopsy BOOP and DAD (exudative phase) ®ndings were present. In one case respiratory failure appeared after a long period in which fever and dyspnoea on eort were the symptoms reported. In the second case rapid respiratory failure appeared during the BOOP relapse after 1 month of steroid withdrawal. In the third case respiratory failure was present from the start and the patient died after 40 days of therapy.
Five patients (asymptomatic patients with cryptogenic organizing pneumonia and roengenological patchy alveolar pattern) recovered spontaneously. In 10 patients with pseudoneoplastic nodules surgery was curative.
Discussion
Most patients in this large series were classi®ed as having idiopathic BOOP. The clinical pattern at presentation of BOOP was more frequently similar to classical acute or sub-acute infectious pneumonia. Fever, dyspnoea, and dry cough were the typical symptoms at admission. A¯u-like syndrome preceeding BOOP was observed in 21 cases (27%). Inspiratory crackles were the most typical ®nding at physical examination. However 13% of the patients were asymptomatic and a nodular shadow on chest X-ray ®lm was the reason for seeking medical attention. It is well documented that the characteristic roentgenographic feature of BOOP is patchy air-space consolidation. This pattern was seen in 88% of the cases of this series. In 44% of the cases there was a unilateral consolidation with lower ®eld predominance. This data, not completely in agreement with other series (4,5), could be explained by the fact that we used bronchoscopic procedures routinely in patients with alveolar shadows on chest X-ray ®lm. It is interesting to note that a migratory behaviour was present in 22% of the cases. This was thought to be a characteristic feature of eosinophilic pneumonia but it is well also documented for BOOP (5) . HRCT scan, when performed was more sensitive to detect ground glass in®ltrates and a more diuse parenchymal involvement, the sub-pleural or peri-bronchovascular distribution of the lesions or the presence of nodules (18) . The HRCT scan ®ndings at presentation are, however, non-speci®c and the dierential diagnosis should include various entities (18) .
In two cases (2Á5%) a rapid progressive respiratory failure needing mechanical ventilation was observed. In another two cases respiratory failure appeared after a long period, during which patients experienced exertional dyspnoea and low-grade fever. In one of these last two cases at autopsy patchy areas of bronchiolitis obliteransorganizing pneumonia (BOOP) and diuse alveolar damage (DAD) in exudative phase were both documented. This may be due to oxygen therapy but also suggests that a phenomenon already described in usual interstitial pneumonitis (UIP/accelerated phase) may be a cause of respiratory deterioration, although rare, in BOOP. In fact, Yousem et al. (19) reported that scarring and remodelling of the background lung parenchyma may be a potential morphologic marker of unfavourable outcome in BOOP patients but other authors reported diuse alveolar damage (exudative phase) in association with BOOP in patients with rapidly progressive respiratory failure (14, 20) . BOOP was related to infections (as documented by serology) in three cases, and was successfully treated only with steroids in all cases. These data suggest the possibility that in some instances the aetiology may be an atypical response to an infectious agent.
Secondary BOOP was observed in 25 cases (32%), clinical pro®le and radiological patterns were similar to those observed in diuse BOOP (idiopathic alveolar/ interstitial patchy variant).
Lymphocytosis with a reduction of the CD4/CD8 ratio associated with a slight increase of neutrophils and eosinophils and scattered mast cells are the BAL hallmark of BOOP of known or cryptogenic aetiology (2, 15, 17, 21) . However in two cases we had an increased CD4/CD8 ratio and in one case the presence of a signi®cant 12% of polyclonal B cells. It is interesting to note that in a few cases atypical (cytokeratin-positive cells) epithelial cells were detected: these cells were constantly present in the BAL uid of patients with rapid progressive respiratory failure and this data con®rms the presence of some relationship between BOOP and diuse alveolar damage as atypical epithelial cells and extracellular amorphous material are a cytological hallmark of diuse alveolar damage in its early phases (22) .
From the diagnostic point of view our study documents that transbronchial lung biopsy (coupled with BAL) should be the ®rst diagnostic step. We had a diagnosis of BOOP by TBB in 58 cases (74%), a diagnostic yield expected in alveolar ®lling diseases epecially when more then ®ve specimens are obtained (16, 17) . Although the sensitivity of BAL was found to be lower than TBB, the combination of the two procedures improved the diagnostic yield (sensitivity 86%). As described previously, we chose arbitrary cuto levels for the BAL percentages of cells (coupled with a CD/CD8 ratio 5 0Á9) to consider the examination as positive for BOOP. In addition, BAL is useful in order to exclude other disorders in particular infectious diseases or neoplastic alveolar ®lling processes (bronchioloalveolar cell carcinoma and low grade B cell lymphoma of MALT type that can be included in the dierential diagnosis list). Thus, in our opinion, BAL can be useful and therapy can be started on the basis of BAL data (when a characteristic morphological and phenotypical pro®le is evident) in cases in which the clinical presentation is suggestive and a biopsy cannot be made (15, 17) .
In this study, although recurrence of symptoms and chest X-ray abnormalities on reducing the steroid dose or shortly after stopping therapy was observed in 26% of the cases, most patients with diuse (idiopathic non-focal or nodular variant) BOOP showed a rapid and good response to therapy.
However, three patients died in spite of steroid therapy (two cases) and steroid and cyclophosphamide therapy (one case). Respiratory failure was present from the start in only one case. In the other two cases it appeared after a long period in which more typical symptoms of BOOP were present and a short course of steroid therapy was performed without having a speci®c diagnosis. BAL showed atypical cells in all cases with rapid progressive respiratory failure. Neutrophils were higher in these patients. Some authors suggested that a high lymphocytic count may indicate a good response to therapy, whereas an increase in neutrophils and/or eosinophils without an additional increase in lymphocytes may predict a poor response (14, 21) . In this series neutrophils increased in patients with a poor prognosis but probably the presence of atypical epithelial cells (best detected by Papanicolou stain), indicating the presence of alveolar damage was more characteristic. This element may have some prognostic signi®cance.
In focal BOOP (idiopathic nodular variant) the surgery was curative.
In conclusion, our study con®rms that BOOP is probably a more than trusted common idiopathic condition or is related to a variety of causes. Although clinical ®ndings, chest X-ray ®lm and CT scan ®ndings usually suggest the diagnosis, a de®nitive con®rmation requires TBB and BAL and less frequently open lung biopsy.
The prognosis is usually good but mortality related to the disease is not negligible; BAL can give us elements to predict response to therapy. How long the treatment should be continued after initial recovery from BOOP to prevent relapse is not yet known. Multi-centric studies with a large number of patients are needed before de®nite conclusions can be drawn on treatment, prognostic elements and risk factors (23, 24) .
